Atlas Trials

Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis

Clinical trial NCT07396467 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07396467
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer (Diagnosis)Pulmonary FibrosisInterstitial Lung Diseases
Start date
2025-11-01
Primary completion
2026-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.